Navigation Links
Scientists Gather to Discuss Novel Uses of Caliper Life Sciences' Discovery Platforms and Technology
Date:6/29/2009

- Recent 'Innovation for Experimentation' Series Attracts Over 350 Attendees -

HOPKINTON, Mass., June 29 /PRNewswire-FirstCall/ -- Caliper Life Sciences, Inc. (Nasdaq: CALP), a leading provider of tools and services for drug discovery and life sciences research, reports that more than 350 customers recently attended its "Innovation for Experimentation" seminar series and open house events held in California and Massachusetts. The seminar series showcased how customers were successfully deploying technologies from Caliper to accelerate drug discovery research.

The events were held in San Francisco, San Diego and Hopkinton to discuss the importance of Caliper's automation, microfluidics, and in vivo imaging technologies. Key themes included approaches for obtaining higher fidelity data that better predict human outcomes, increasing throughput and unattended run time while being cognizant of optimizing higher order workflows, decentralizing testing to ensure information is available in real time to decision makers, and increasing the knowledge generated per dollar, hour, and number of samples.

"The life sciences industry is tasked with the noble mission of finding cures and treatments for the sick and suffering," said Kevin Hrusovsky, CEO of Caliper Life Sciences. "Our symposium series 'Innovation for Experimentation' enables us to better align our internal research priorities and investments with customer requirements to ensure that we develop technologies that enable our customers to be successful in increasing the quality and length of life. This year's series was the best attended in years primarily due to our new comprehensive suite of 'breakthrough' LabChip, IVIS and Zephyr platforms."

The events featured customer presentations focused on the adoption of Caliper platforms to accelerate discovery research at the following institutions: Pfizer, Merck, EMD Serono, Amgen, ArQule, Dana Farber Cancer Institute, Boehringer-Ingelheim, Wyeth, Calloway Labs, University of Massachusetts, Genencor, Bristol-Myers Squibb, XcellereX, SUNY Upstate, Vertex, Dow Biopharma, Symbiosis, MacroGenics, Geron, Elan, Roche, and the National Cancer Institute. The open house event in Hopkinton featured a keynote presentation from Kevin Hrusovsky, which is available online: http://www.caliperls.com/investors/open-house-061909-ceo-presentation.php.

Investors and analysts were also invited to attend and participate in a separate breakout session featuring presentations by Kevin Hrusovsky, President and CEO, as well as several members of Caliper's executive team, who outlined Caliper's strategic priorities and the future direction of Caliper's technologies and services. A webcast of this breakout session is available online: http://phx.corporate-ir.net/phoenix.zhtml?c=85833&p=irol-EventDetails&EventId=2268770.

About Caliper Life Sciences

Caliper Life Sciences is a premier provider of cutting-edge technologies enabling researchers in the life sciences industry to create life-saving and enhancing medicines and diagnostic tests more quickly and efficiently. Caliper is aggressively innovating new technology to bridge the gap between in vitro assays and in vivo results and then translating those results into cures for human disease. Caliper's portfolio of offerings includes state-of-the-art microfluidics, lab automation & liquid handling, optical imaging technologies, and discovery & development outsourcing solutions. For more information please visit www.caliperLS.com.

Caliper, LabChip, IVIS, and Zephyr are registered trademarks of Caliper Life Sciences, Inc.


'/>"/>
SOURCE Caliper Life Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. New prion protein discovered by Canadian scientists may offer insight into mad cow disease
2. Scientists Probe Sepsis Deadly Secrets
3. Scientists puzzled by severe allergic reaction to cancer drug in the middle Southern US
4. Scientists Develop Natural Protection for Stored Foods
5. Scientists detect presence of marburg virus in african fruit bats
6. Scientists Spot Brains Free Will Center
7. Scientists ID Likely Culprit in Popcorn Lung
8. Scientists explain how insulin secreting cells maintain their glucose sensitivity
9. Scripps Research scientists shed new light on how antibodies fight HIV
10. Scientists, physicians present latest findings in personalized cancer treatment and prevention
11. Scientists demonstate link between genetic variant and effectiveness of smoking cessation meds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... February 23, 2017 , ... The 89th Academy Awards ... of the 2016 National Education Policy Center Bunkum Award. We invite you to enjoy ... , This year’s Bunkum winner is the Center for American Progress (CAP), for its ...
(Date:2/23/2017)... ... February 23, 2017 , ... Hamlin Dental Group and Dr. ... are sponsoring a raffle. Throughout the month of February, patients who visit Hamlin Dental ... card for a dinner for two at the Cheesecake Factory. , Tickets are ...
(Date:2/23/2017)... Colorado (PRWEB) , ... February 23, 2017 , ... ... Magazine, an exciting, new, interactive publication where generations converge and explore the world ... expand their worldview, Dialog Magazine enables readers to gain understanding, increase empathy, and ...
(Date:2/23/2017)... ... (PRWEB) February 23, 2017 -- ... to come together to combine its favorite springtime pastime – ... fruit – apples! To celebrate National Nutrition Month, the U.S. ... Madness” bracket tournament – a five-week, five-round online competition spotlighting ...
(Date:2/23/2017)... ... February 23, 2017 , ... Thomas Vas-Don suffered ... exercise regime, the author was able to successfully recover. In “ Origin & Insertion ... for various sources on the principals of massage, anatomy , trigger points ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... Feb. 23, 2017 Research and Markets has ... Strategies - 2016" report to their offering. ... The latest research Fibromyalgia Drugs ... benchmarks in the global Fibromyalgia market. The research answers ... drugs marketed for Fibromyalgia and their clinical attributes? How are they ...
(Date:2/23/2017)... , Feb 23, 2017 Research and ... Analysis & Trends - Industry Forecast to 2025" report to ... ... of around 6.9% over the next decade to reach approximately $47.6 ... market estimates and forecasts for all the given segments on global ...
(Date:2/23/2017)... 2017  MiMedx Group, Inc. (NASDAQ: MDXG), the leading ... processes to develop and market advanced products and therapies ... Ophthalmic, and Dental sectors of healthcare, today announced its ... ended December 31, 2016. Full Year 2016 ... 31% increase over full year 2015 revenue ...
Breaking Medicine Technology: